Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemoembolization, Therapeutic | 1 | 2016 | 16 | 0.540 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2016 | 92 | 0.510 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 163 | 0.460 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 334 | 0.410 |
Why?
|
| Glucose-6-Phosphatase | 5 | 2010 | 8 | 0.400 |
Why?
|
| Cysts | 2 | 2021 | 70 | 0.300 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 110 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 206 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 332 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2324 | 0.150 |
Why?
|
| Islets of Langerhans | 2 | 2008 | 87 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 5 | 2010 | 615 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 373 | 0.140 |
Why?
|
| Ethiodized Oil | 1 | 2016 | 4 | 0.140 |
Why?
|
| User-Computer Interface | 1 | 2016 | 230 | 0.120 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2014 | 9 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 1293 | 0.110 |
Why?
|
| Contrast Media | 1 | 2016 | 595 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2014 | 175 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2009 | 5 | 0.100 |
Why?
|
| Fasting | 1 | 2010 | 75 | 0.090 |
Why?
|
| Biocatalysis | 1 | 2009 | 23 | 0.080 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2008 | 1 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 95 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 191 | 0.080 |
Why?
|
| Gluconeogenesis | 1 | 2006 | 7 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 562 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 94 | 0.070 |
Why?
|
| Insulin | 1 | 2009 | 619 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 1173 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 215 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7029 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 474 | 0.060 |
Why?
|
| Humans | 7 | 2021 | 68618 | 0.050 |
Why?
|
| Liver | 2 | 2021 | 1118 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 2358 | 0.050 |
Why?
|
| Machine Learning | 1 | 2021 | 170 | 0.040 |
Why?
|
| Male | 3 | 2019 | 37321 | 0.040 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2019 | 31 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2021 | 193 | 0.040 |
Why?
|
| Middle Aged | 1 | 2016 | 21147 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 8474 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1342 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1753 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3259 | 0.030 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2014 | 2 | 0.030 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2014 | 12 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2014 | 110 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2008 | 1851 | 0.030 |
Why?
|
| Finland | 1 | 2010 | 13 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 68 | 0.020 |
Why?
|
| Animals | 4 | 2009 | 20881 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 167 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 302 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 171 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2010 | 220 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2009 | 4 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 579 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 849 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 8 | 0.020 |
Why?
|
| Mothers | 1 | 2010 | 172 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 99 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2010 | 241 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 262 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 159 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2007 | 8 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 88 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 105 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 157 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 63 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 282 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 191 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 627 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 631 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 357 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2008 | 237 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 631 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 29 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 782 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 1033 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 1752 | 0.010 |
Why?
|
| Female | 2 | 2019 | 38074 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 1213 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2673 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 529 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2077 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 5300 | 0.010 |
Why?
|
| Child | 1 | 2010 | 6405 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 21403 | 0.010 |
Why?
|